In the past week, GRI stock has gone up by 9.64%, with a monthly gain of 106.85% and a quarterly surge of 95.44%. The volatility ratio for the week is 11.34%, and the volatility levels for the last 30 days are 24.82% for GRI Bio Inc The simple moving average for the last 20 days is 9.29% for GRI stock, with a simple moving average of -78.42% for the last 200 days.
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
The 36-month beta value for GRI is at -1.96. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRI is 2.92M, and currently, shorts hold a 31.67% of that float. The average trading volume for GRI on November 15, 2024 was 4.38M shares.
GRI) stock’s latest price update
GRI Bio Inc (NASDAQ: GRI)’s stock price has increased by 9.12 compared to its previous closing price of 0.88. However, the company has seen a 9.64% increase in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-14 that $13.9 million in gross proceeds raised since the beginning of 2024 extending expected cash runway into mid Q1 2025 and through interim data readout from GRI-0621 Phase 2a biomarker study
GRI Trading at 56.26% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.16% of loss for the given period.
Volatility was left at 24.82%, however, over the last 30 days, the volatility rate increased by 11.34%, as shares surge +96.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +95.92% upper at present.
During the last 5 trading sessions, GRI rose by +9.64%, which changed the moving average for the period of 200-days by -95.44% in comparison to the 20-day moving average, which settled at $0.8784. In addition, GRI Bio Inc saw -97.26% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.6 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -1.79. Equity return is now at value -189.06, with -130.64 for asset returns.
Currently, EBITDA for the company is -10.9 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.11.
Conclusion
In conclusion, GRI Bio Inc (GRI) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
